A reasonable question is why the documented figure sits where it does rather than higher
Research indicates that up to 25-40% of weight lost on GLP-1 agonists alone may come from muscle, making anabolic support increasingly popular among research communities
Liraglutide , marketed under the brand name Saxenda, is one such treatment approved for chronic weight management in individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related condition
Williams et al Circulation and degradation of GIP and GLP-1 Hormone Metab Res
Of course, that fat has to be the anti-inflammatory kind - think guacamole and canned coconut milk, not potato chips and fried chicken
First, lets talk about what compounded drugs are and how theyve changed the GLP-1 market